Almost one in five children born to mothers taking antidepressants during pregnancy have a brain defect – called a “Chiari type 1 malformation” – according to a groundbreaking study by researchers at the University of North Carolina at Chapel Hill.
The study, titled Rate of Chiari I Malformation in Children of Mothers with Depression with and without Prenatal SSRI Exposure, was published May 19 in the peer-reviewed journal Neuropsychopharmacology.
The researchers found that “children of depressed mothers treated with a group of antidepressants called selective serotonin reuptake inhibitors (SSRIs) during pregnancy were more likely to develop Chiari type 1 malformations than were children of mothers with no history of depression,” according to their press statement.
So-called SSRI antidepressants encompass almost all of today’s major brands, including Prozac, Paxil, Luvox, Zoloft, Celexa and Lexapro. According to the Centers for Disease Control and Prevention, in 2010 an astonishing 254 million prescriptions for antidepressants were written for Americans. And between 7 and 13 percent of all pregnant women in the U.S. are currently taking them, even though virtually every study performed to date demonstrates that mothers taking SSRIs – especially in the first trimester of pregnancy – significantly increase the risk of their giving birth to children with autism, as well as other disorders and birth defects.